Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.

Source:http://linkedlifedata.com/resource/pubmed/id/18452724

Download in:

View as

General Info

PMID
18452724